Wellthy Therapeutics Private Limited, a active private limited company, was established on 02 December 2015 in Mumbai, Maharashtra, India. Engaging in online healthcare services within the hospital and medical care sector, it holds CIN: U93030MH2015PTC270628. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹7.20 Cr and a paid-up capital of ₹5.99 Cr.
It upholds a compliant status. Employing 38 professional, Its leadership includes Prayat Aasit Shah (Director), Amit Chhajer (Nominee Director), Abhishek Nikhil Shah (Director). Past directors included Suresh Shanmugham, Jasdeep Singh, Kunal Anil Khanna. Its latest AGM occurred on 23 September 2025, with the balance sheet filed on 31 March 2025. It is based at 20, Nagin Mahal, 5Th Floor,82, Veer Nariman Road, Churchgate, Mumbai, Maharashtra, 400020.
U93030MH2015PTC270628
270628
02 December 2015
₹7.20 Cr
₹5.99 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Wellthy Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prayat Aasit Shah | Director | 26 Apr 2024 | Current |
| Amit Chhajer | Nominee Director | 28 Jun 2024 | Current |
| Abhishek Nikhil Shah | Director | 02 Dec 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Nominee Director | 26 Apr 2024 | Past |
| Pramod Abcsdd | Nominee Director | 06 Mar 2024 | Past |
| Pramod Abcsdd | Nominee Director | 16 Aug 2020 | Past |
| Pramod Abcsdd | Nominee Director | 26 Apr 2024 | Past |
| Pramod Abcsdd | Nominee Director | 24 Jan 2025 | Past |
| Pramod Abcsdd | Director | 11 Aug 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Wellthy Therapeutics Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Wellthy Therapeutics had a promoter holding of 92.81% and a public holding of 7.19%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Wellthy Therapeutics has a workforce of 38 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Wellthy Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wellthy Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Wellthy Therapeutics Private Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Wellthy Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Amit Chhajer was appointed as a Nominee Director was appointed as a Nominee Director on 28 Jun 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.
The activity Prayat Aasit Shah was appointed as a Director was appointed as a Director on 26 Apr 2024 & has been associated with this company since 1 year 7 months . was completed.
Abhishek Nikhil Shah was appointed as a Director was appointed as a Director on 02 Dec 2015 & has been associated with this company since 9 years 11 months . was recorded as a recent event.
Progress on Wellthy Therapeutics Private Limited was registered on 02 Dec 2015 with Roc Mumbai & aged 9 years 11 months as per MCA records. was documented.
The CIN of Wellthy Therapeutics Private Limited is U93030MH2015PTC270628.
Wellthy Therapeutics Private Limited is headquartered at 20, Nagin Mahal, 5Th Floor,82, Veer Nariman Road, Churchgate, Mumbai, Maharashtra, 400020.
Wellthy Therapeutics Private Limited was incorporated on 02 December 2015.
The current directors of Wellthy Therapeutics Private Limited are
The primary industry of Wellthy Therapeutics Private Limited is Hospital And Medical Care.
Wellthy Therapeutics Private Limited is unlisted.
The authorized capital of Wellthy Therapeutics Private Limited is ₹7.20 Cr, and the paid-up capital is ₹5.99 Cr.
The compliance status of Wellthy Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX